Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Re: I didn't realize they were given 3-50mg doses. I thought the range was 30-50mg. Is that 3mg correct? Don't recall seeing it.
If I recall correctly, 3mg-5mg were the IV dosages.
Stongly agree. This is nothing more than a last ditch effort to short and distort prior to positive news.
Doc the Hoople!
Correct, but not paid to promote or give guidance.
After the coordinated short attack in Nov, I prefer that the company provide their positive data in a "surprise" fashion, so not to give the criminal cartel a heads up.
Maxim is an investor. See the S-1. I seriously doubt they're paid by Anavex.
I don't think so... I believe it's a linear scale, where 5 wks is part of the 12 wks. Doesn't make sense to reset the scale.
that was 5-wk data... so adding 7 weeks should put it in January.
If you aren't familiar with coordinated short attacks, then you really shouldn't be investing/trading in small cap biotechs. There have been numerous posts and links identifying such. I recommend that you Google it.
It's not that difficult to see. It's going up today because the orchestrated shorting machine is turned off. The price was manipulated down to close out the year to enhance their bonuses, now they are beginning to unwind/cover their short positions in anticipation of good news coming this month.
Aren't you afraid of this taking off and not covering your short?
Nope... holiday.
Attention shoppers, the store is closing and the special is over. You'll have to pay more on Monday!
Shorts are climbing over themselves rushing to the "cover" door!
Haha... Kevin wants his $800 back.
You're forgetting about large short covering beginning next year. This will begin the SP rise and start attracting new buyers.
Buy EOD. The short hedgies' and MMs' are driving it down to maximize their reporting results and bonuses. They will begin to cover their short positions next week.
Yes, but we're talking about the shorts. They will wait until next week to start covering. The manipulation this week, EOY, is to maximize their reporting gains and of course their bonuses.
I'm not "shutting my eyes". My eyes are wide open and buying more! Tomorrow should be an even better buying spree!
It's the new year. The shorting manipulative machine will be turned off and likely will be put into reverse...i.e. covering.
You are an example of how the financial terrorist win. They scare retail into selling and grab their shares on the cheap. It is why they keep playing the games, because they know they can instill fear. Next week and month will be a much different game, with huge upside. I wouldn't want to be out come Monday morning.
Melissa Davis of StreetSweeper: In Bed with Short Sellers and Convicted Felons
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=76192010
Yes, as well as they want to clear the market (i.e. SEC action) of the nefarious and criminal element which has been attacking AVXL and other promising biotechs, to not interfere with progress or, more importantly, their investments.
It's more of a scam to attract gullible investors to buy into a fictitious class action suit that will never materialize. A BIG SCAM to suck more money from investors.
If you missed today's buying opportunity, you might get another chance on Thursday... when the hedgies and MMs work to maximize their EOM, EOQ and EOY bonuses. Just wait until late in the day.
This manipulation will be just a blip on the way to a big and bright future for AVXL... all beginning Jan 4. Get your tickets now!
Yes...that's the good thing about this side of solstice. :)
Makes winter more bearable! That and AVXL! Cheers!
With AVXL, won't need $2B in funding...
That's incorrect... A2-73 IS shown to be effective on its own... it's just better with donepezil, for those who are moderately afflicted with AD and have a Beta Amyloid buildup.
Just watched Cramer "dancing" around the subject of him hiring Shkreli as an intern for his firm. Cramer said he had left the firm before Shkreli was advanced... (my ed: but not before he trained him!) They're all criminals! I have a renewed disrespect for Cramer, whom I used to think did good.
This is AWESOME! Next is AF and JF...
As I understand, they wouldn't be able to "exercise" the option out of the money, but could try to sell it.
Although, "they" just might manipulate the price to keep it below $7.50 Friday so that the options expire worthless.
We're absolutely NOT like AXON, but seems their weakened position is supported by an overvalued MC. If their drug is ineffective or less effective, then why isn't someone reporting on that? That would certainly enable me to establish my short position.
Someone needs to write a hit piece on AXON!
According to the March S-1, in March 2014, there were a number of institutions purchasing Convertible Debentures (pre-split), $10M in aggregate. It doesn't detail the amount for each...
Recent Sales of Unregistered Securities.
Our Company has issued the following securities during the past three (3) years without registering the securities under the Securities Act:
On October 22, 2014, the Company entered into a Securities Purchase Agreement with Lincoln Park, for an equity investment of $500,000 at $0.25 per share of the Company’s common stock. Pursuant to the terms of such purchase agreement, the Company agreed to sell, and Lincoln Park agreed to purchase, 2,000,000 shares of common stock. In addition to such shares, the Company agreed to issue to the Lincoln Park two series of warrants representing the right to purchase an aggregate of 4,000,000 shares of Common Stock. The securities were issued pursuant to an exemption from registration pursuant to the provisions of and related to Section 4(a)(2) of the Securities Act.
On March 13, 2014, the Company entered into a Securities Purchase Agreement with certain purchasers identified therein pursuant to which the Company agreed to sell, and the purchasers agreed to purchase, Senior Convertible Debentures due March 18, 2044 in the aggregate principal amount of $10,000,000. In addition to the Debentures, the Company agreed to issue to the purchasers two series of warrants representing the right to purchase up to an aggregate of 67,666,666 shares of the Company’s common stock. The purchase and sale of the debentures and warrants was consummated on March 18, 2014, and resulted in gross proceeds to the Company in the amount of $10,000,000, before deducting agent fees and other transaction-related expenses. The purchasers were: Auriga Global Investors SU, SA; Auriga Investors-Montserrat Global Fund; Hudson Bay Master Fund LTD; DAFNA LifeScience LP; DAFNA LifeScience Market Neutral L.P.; DAFNA LifeScience Select L.P.; Joann Mostovoy; Sabby Healthcare Volatility Master Fund, Ltd.; Sabby Volatility Warrant Master Fund, Ltd.; Sphera Global Healthcare Master Fund; and HFR HE Sphera Global Healthcare Master Trust. Additionally, in connection with the transaction, Maxim Partners LLC (an affiliate of Maxim Group LLC who served as the exclusive placement agent), was issued warrants representing the right to purchase up to an aggregate of 1,000,000 shares of the Company’s common stock. The securities were issued pursuant to an exemption from registration pursuant to the provisions of and related to Section 4(a)(2) of the Securities Act.
Perhaps a good dose of short covering mixed in?
I'm surprised YOU'RE hanging in there, shorty!
News leaking or temporary pump?
Nice going... Hopefully, they were already in tune, but never hurts.
Yes, of the two, green is the most preferred Christmas color!